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Background: Amphiphilic peptides are important building blocks to generate nanostructured biomaterials for drug
delivery and tissue engineering applications. We have shown that the self-assembling peptide SA2 (Ac-AAVVLLLWEE)
can be recombinantly produced in E. coli when fused to the small ubiquitin-like modifier (SUMO) protein. Although this
system yielded peptides of high purity with no residual amino acids after cleavage of the SUMO fusion protein, the
yield after purification was generally low (~1 mg/L bacterial culture) as compared to other peptides and
proteins produced with the same method and under the same conditions.
Results: The aim of this study is to understand the underlying mechanisms causing the low yield of this
recombinant peptide in E. coli and to optimize both production and purification of recombinant SA2
peptides. It was demonstrated that by simply changing the medium to a well-balanced auto-induction
medium the yield of recombinant production was augmented (~4 fold). Moreover, it was demonstrated that
self-assembly of SUMO-SA2 fusion proteins caused the low peptide yields after purification. By replacing the
second IMAC purification step with a selective precipitation step, peptide yields could be increased approx. 3
fold. With these optimizations in place the overall yield of purified SA2 peptide increased with 12-fold.
Conclusion: Premature self-assembly of the SUMO-SA2 fusion construct interfered with proper purification of the SA2
peptide, resulting in low yields of purified peptide and this could be prevented by changing the mode of purification.
These findings are important when setting up purification schemes for other self-assembling peptides with the use of a
SUMO fusion construct.
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Amphiphilic peptides (Aps) represent a group of
small peptides with sequestered hydrophobic and
hydrophilic domains. Their amphiphilic nature allows
them to self-assemble into supramolecular structures,
such as micelles, nanotubes, belts or vesicles with in-
teresting applications in drug delivery and tissue en-
gineering [1-10].
Aps are produced by solid-phase peptide synthesis
(SPPS) [11,12] but also recombinantly in bacteria and
yeast [13-16]. Production of Aps via SPPS has some lim-
itations. The presence of large stretches of hydrophobic* Correspondence: E.Mastrobattista@uu.nl
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article, unless otherwise stated.amino acids in Aps may cause collapse of the peptides
on the solid support, which increases the risk of trun-
cated peptides that even become more problematic in
large scale synthesis [17]. Such truncated peptides which
often differ in only one amino acid from the full length
peptide, are difficult to remove during subsequent purifi-
cation steps. It was shown that such impurities can have
profound effects on the self-assembling behavior of these
Aps [17]. Besides purity, high scale production of SPPS
is costly [18,19].
Numerous attempts have been made for recombinant
production of relatively small, self-assembling peptides.
However, such methods have encountered several chal-
lenges: their amphiphilic nature and tendency to self-
assemble can cause toxicity problems in the production
cells or can lead to proteolytic degradation or sequesteringCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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fused to a larger chaperone proteins [21].
One such fusion construct that favors soluble produc-
tion of small hydrophobic peptides is the small ubiquitin-
like modifying protein (SUMO) [21]. It can protect the
protein/peptide by using its chaperoning properties,
enhance the solubility and increase production [20]. This
relatively small fusion protein (12.2 KD) can be specifically
cleaved and separated from its fused partner by SUMO
protease [22]. An important advantage of the SUMO
fusion protein technology is that it generates peptides with
a native N-terminus without residual amino acids after
cleavage with SUMO protease [22,23]. In previous studies,
we have used the SUMO fusion technology for the recom-
binant production and purification of a 10 amino-acid
amphiphilic peptide called SA2 (AAVVLLLWEE) in E. coli
[6]. The fusion protein consisted of a 6 residue histidine
tag at the N-terminus for purification, SUMO for stability
and solubility and the SA2 peptide at the C-terminus.
Cleavage of the fusion protein with SUMO protease en-
abled the release of SA2 without any residual amino acids
(Figure 1). Since SA2 self-assembles into nanovesicles, the
SUMO fusion technology was used to prevent premature
self-assembly of the peptides into supramolecular struc-
tures and to keep the monomeric peptide soluble during
recombinant production. Although we succeeded to purify
SA2 peptides following this approach, the yield was rather
low, with approximately 1 mg of purified SA2 peptide/L
bacterial culture.
In this study, the aim was therefore to determine and
optimize the critical steps in the production and purifi-
cation scheme of SA2 that limits the purified peptide
yield and to maximize production yields of SA2 peptide.
Results and discussion
Peptide biosynthesis
To increase the yield of purified recombinant SA2,
we first focused on the optimization of production of
SUMO-SA2 in E. coli. Production of potentially toxic
proteins generally does not benefit from the use of
strong promoters to maximize transcription levels.
Instead, tight control over the induction of expression
is necessary to prevent premature expression and sub-
sequent toxicity to the host. Strategies that enable
induction of expression at high cell densities using
auto-induction medium have been used to yield goodFigure 1 Schematic illustration of 6His-tagged SUMO-SA2. SUMO prot
SA2 peptide.levels of recombinant proteins [24]. Moreover, auto-
induction media have the added advantage of very
low to no expression prior to the time of induction
because of the catabolyte repression effect of glucose,
which makes it particularly suitable for the expression of
potentially toxic recombinant proteins [25]. Here, we
tested two different media for recombinant production of
SA2: 1). Standard LB medium with IPTG as irreversible
inducer of SUMO-SA2 expression under control of the
T7lac promoter, and 2). ZYM medium, which leads to
auto-induction of SUMO-SA2 expression based on glu-
cose as preferable carbon source for E. coli. A restricted
concentration of glucose not only is consumed preferen-
tially during growth but also inhibits uptake of lactose.
After consumption and depletion of glucose to reach a
high cell density, lactose will be taken up and converted to
the allolactose which is an inducer for T7 RNA polymer-
ase expression under control of the lacUV5 promoter and
unblocks the T7lac promoter, leading to high levels of
expression [24]. A 5 ml overnight culture of E. coli was
diluted in 1000 ml of LB or ZYM medium followed by in-
cubation at 37°C in a shaking incubator. OD600 was moni-
tored for LB medium and IPTG was added when the
OD600 was ~0.4. Four hrs after induction with IPTG (in
case of LB medium) and 16 hrs after inoculation (in case
of ZYM medium) the wet weight of the bacterial pellet
was determined (Table 1). A higher biomass (~3.5 fold)
was reached using the ZYM autoinduction medium in
comparison with IPTG induction in LB medium [24].
SUMO-SA2 purification
After induction, E.coli cells were harvested and lysed.
Cleared lysate was used for further purification of the
SUMO-SA2 construct using Ni2+-NTA immobilized
metal affinity chromatography. Eluted proteins were sub-
jected to a buffer exchange with HEPES, pH 8.0 using a
Hiprep 26/10 desalting column. Determination of total
amount of SUMO-SA2 after desalting based on its ex-
tinction coefficient at 280 nm (6990 M−1 cm−1) indicated
higher protein yield per volume (~3.8 time) using the
ZYM autoinduction medium in comparison with IPTG
induction in LB medium (Table 1).
SDS-PAGE analysis of SUMO-SA2 before and after
desalting showed a major protein band with good
purity at 16 kD and a smaller, less intense band at 14
kD) (Figure 2). Further analysis of the purified andease can specifically cut the recombinant construct and release the
Table 1 Yield of biomass, SUMO-SA2 and SA2 (mg) produced per liter of LB or ZYM medium






LB + 1 mM IPTG 2.18 ± 0.11 63 ± 2 5.04 ± 0.18 4.26 ± 0.15 3.20 ± 0.20
ZYM (Auto induction) 7.62 ± 0.03 243 ± 5 19.44 ± 0.45 16.21 ± 0.32 12.16 ± 0.43
These results show that compared to induction with IPTG, the auto induction medium significantly increased SUMO-SA2 production and subsequently the yield of
purified SA2 peptides (>3.8 times).
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revealed two peaks (Figure 3, dashed line), of which the
first peak eluted in the void volume of the column with a
retention volume of 7.5 ml. The second peak eluted at
11.2 ml, with the same retention volume of a 14 kD globu-
lar protein (ribonuclease A). This indicated that SUMO-
SA2 was present in monomeric as well as aggregatedFigure 2 SDS-PAGE analysis of purified SUMO-SA2. Lane 1: 3 μl
PageRuler™ Prestained Protein Ladder (Fermentas, Vilnius, Lithuania).
Lane 2: 25 μl of purified SUMO-SA2 before desalting. Lane 3: same
as lane 2, but 10x diluted in sample buffer. Lane 3: 25 μl of purified
SUMO-SA2 after desalting. Lane 4: same as lane 3 but 10x diluted in
sample buffer.form. This can be explained by the hydrophobic nature of
SA2 peptide causing the formation of aggregates. We
assumed that the attachment of SUMO would prevent
premature self-assembly of SA2 in bacteria, allowing us to
purify the soluble fusion protein directly from the cleared
lysates in a two-step metal affinity chromatography purifi-
cation [6,20].
Here we showed that the presence of the SUMO fu-
sion protein, although beneficial for expression levels of
the SA2 peptide, did not completely prevent premature
aggregation of the peptide-fusion construct.
SUMO-SA2 cleavage
Next, SUMO-SA2 was cleaved with SUMO protease to
release the SA2 peptide from the SUMO protein. SUMO
protease was added to the SUMO-SA2 solution at a
mass ratio of 1:500, and the mixture was incubated at
30°C for 6 hrs with gentle shaking. To monitor the en-
zymatic cleavage of SUMO-SA2, analytical size exclusion
chromatography (SEC) was used (Figure 3, solid line).
Before cleavage of SUMO-SA2, two peaks can be dis-
cerned, with the first peak eluting in the void volume of
the SEC column and the second peak corresponding
with monomeric SUMO-SA2. SDS-PAGE analysis con-
firmed that both peaks consisted of SUMO-SA2 only,
suggesting that the first peak consists of a multimeric or
aggregated form of SUMO-SA2. As expected, after
cleavage a third peak at a retention volume of 15.9 ml
appeared, which contained full length SA2 (as confirmed
by mass spectrometry). Furthermore, after cleavage an
increase in the area under the curve (AUC) of peak 1
and a decrease of AUC of peak 2 were observed,
suggesting an increase in protein in the multimeric or
aggregated form after cleavage.
To determine the composition of these aggregates,
peak 1 was collected and again injected into the column.
Interestingly, this fraction divided into three peaks, with
the main part being monomeric SA2 peptide (Figure 4,
dashed line). This demonstrated that the aggregate peak
consisted of a mixture of SA2 and SUMO-SA2. In an
attempt to dissolve the aggregates, we raised the pH of
the sample and mobile phase to 11.5 prior to separation.
As shown in Figure 5A, SEC analysis was performed
with phosphate buffered saline (pH 11.5) as the mobile
phase. Interestingly, the AUC for the SA2 peptide peak
clearly increased, while the AUC of the first peak
Figure 3 Size exclusion chromatography of SUMO-SA2 before (dashed red line) and after (solid blue line) enzymatic cleavage with SUMO
protease. Peak 1 corresponds to protein eluting in the void volume, peak 2 corresponds to SUMO-SA2 or cleaved SUMO and peak 3
corresponds to SA2 peptide.
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the pH could dissolve the major part of the aggre-
gates. This finding revealed that at high pH, the por-
tion of SA2 peptides in a soluble, monomeric state
was higher and consequently purification could be
done more easily.
Peptide purification
The original purification scheme for SUMO-SA2 entailed
a two-step IMAC purification scheme in which the first
step was the purification of SUMO-SA2 fusion protein
from the cleared lysate. After cleavage of the purified
SUMO-SA2 with SUMO protease, the His-tagged SUMO
was separated from the released peptide by a second
IMAC step. However, we observed that mixtures of
uncleaved SUMO-SA2 and cleaved SA2 can form aggre-
gates, which caused loss of the SA2 product during theFigure 4 Size exclusion chromatography analysis of cleaved SUMO-SA
three main peaks (solid line). After collection and reinjection of the first
the first peak contained complex aggregates of SUMO-SA2 and SA2.second purification step (Figure 6). For that reason we
adapted the purification scheme.
To separate the cleaved peptide from the SUMO pro-
tein, selective precipitation was applied. The pH of the
protein solution after cleavage was adjusted to pH 11.5.
SUMO, SUMO protease and uncleaved SUMO-SA2
were selectively precipitated by adding ethanol up to
50% (v/v) to the protein solution.
SEC analysis of the supernatant showed a major peak
in the chromatogram, corresponding to the SA2 peptide
which was confirmed by mass spectrometry (M.W.
1142.65 Da) (Figure 7A,C). To determine the yield of
purification, the precipitate obtained after centrifugation
was collected and resuspended in the same buffer and
volume and analyzed by SEC. The chromatogram
showed separation of most of the big proteins and aggre-
gates and also some parts of SA2 (Figure 7B).2 in phosphate buffered saline (pH = 7.4) Chromatogram showed
peak the same three peaks appeared (dashed line). This indicates that
Figure 5 The effect of alkaline medium on SA2 solubility. Size exclusion chromatograms of the SUMO-SA2 protein solution after treatment
by SUMO protease. Phosphate buffered saline pH = 11.5 (A) or phosphate buffered saline pH = 7.4 (B) were used as the mobile phase.
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before and after ethanol precipitation revealed that 75%
of the peptide was recovered in the supernatant (Table 1),
and almost all other proteins were removed by ethanol
precipitation.
Conclusion
In conclusion, the results of this study demonstrated
that premature self-assembly of SUMO-SA2 interfered
with the proper purification of SA2 peptides resulting in
low yields of purified peptide. By refining the purifica-
tion procedure and by altering the expression medium,
we demonstrated a more than 12-fold increase in puri-
fied SA2 peptide from one liter of bacterial culture. Al-
though these findings are specific for the purification of
SA2 peptides, premature self-assembly during recombin-
ant production may also take place with other amphi-
philic peptides, which may to a certain extent explain
the low yields reported for the recombinant productionFigure 6 Schematic representation of IMAC purification and the pept
SUMO protease. Released peptides are able to form aggregates with clea
low and most peptides stick to the column through the His tag of biggerand purification of such self-assembling peptides [21,26,27].
A critical evaluation of the purification scheme of such
peptides may therefore be advisable.Materials and methods
Materials
All chemicals and media were from Sigma-Aldrich (ST.
Louis, USA), unless indicated otherwise. Bicinchoninic
acid (BCA) assay reagent was from Pierce (Rockford,
IL, U.S.A.). DNAse I was from Roche Diagnostics
(Mannheim, Germany) and chicken egg white lyso-
zyme was obtained from Fluka (Buchs, Switzerland;
84,468 U/mg). Hiprep 26/10 desalting and Superdex
Peptide 10/300 columns were purchased from GE
Healthcare, (Uppsala, Sweden). PageRuler™ Prestained
Protein Ladder was from (Fermentas, Vilnius, Lithuania).
Phosphate buffer saline (PBS) was obtained from Braun
(Melsungen AG, Germany).ide loss in 2nd IMAC purification after cleavage of SUMO-SA2 by
ved or uncleaved SUMO-SA2. Collected peptide in the flow through is
proteins.
Figure 7 Peptide purification after enzymatic cleavage through selective precipitation. Selective precipitation was performed by adding
ethanol up to 50% (v/v). A) Analysis of supernatant showed 1 major peak corresponding to SA2 B) SEC analysis of cleaved SUMO-SA2 before
(solid line) and after (dashed line) selective precipitation. C) ESI-MS mass spectrum of the SA2 peptide in the supernatant after
ethanol precipitation.
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Escherichia coli BL21 (DE3) containing the T7 RNA
polymerase under control of the lacUV5 promoter was
purchased from Invitrogen (Breda, The Netherlands).
BL21 (DE3) was transformed with pET-SUMO-SA2 [6]
and pSUPER-dtUD1 constructs (kindly donated by Prof.
Patrick J. Loll) [28] separately according to the pET-SUMO
supplier protocol (Invitrogen, Carlsbad, USA). Briefly,
6.5 ng of the plasmid DNA was added to 50 μl of chem-
ically competent E.coli BL21 (DE3) in a Eppendorf tube
and shaken gently. The tube was put on ice for 30 min
after which the cells were placed in a water bath of 42°C
for 30 sec. Next, the tube was placed on ice. For recovery
of cells, 250 μl of SOC medium was added to the tube. To
make a stock for the transformed E.coli bacteria, 100 μl of
the bacterial suspension was transferred into a LB plate
containing 50 μg/ml of kanamycin and incubated at 37°C
overnight. A single colony was selected and grown in 5 ml
LB overnight. The overnight grown bacteria were cooled
on ice and glycerol was added up to 30% of final volume
before storage at −80°C.Peptide biosynthesis
Media composition and protein expression
LB medium (peptone; 10 g/L, yeast extract; 5 g/L and
10 g/L of NaCl) was used for the pre-culture preparation
and expression of SUMO-SA2 and SUMO protease
(dtUD1). Auto induction medium (ZYM) was made
according to the Studier method [24] and was used for
SUMO-SA2 expression. In short, 1 L of ZYM medium
that contained Tryptone (10 g/l), Yeast Extract (5 g/l),
MgSO4 (1 mM), 20 mL of 50 × 5052 solution (glycerol
250 g/l, glucose 25 g/l, alpha lactose 100 g/l in RO
water), kanamycin (100 mg/l) and 50 ml of 20× NPS
solution ((NH4)2SO4 (66 g/l), KH2PO4 (136 g/l), Na2HPO4
(142 g/l). One liter of autoclaved ZYM or LB media was in-
oculated with 5 ml of overnight seed culture of the
transformed E. coli strain BL21 (DE3). LB medium was
incubated in a shaking incubator (Innova 4335, New
Brunswick Scientifc,USA) at 37°C/250 rpm and induced
with 1 mM IPTG when the culture reached OD600 = 0.6-0.8.
Next, bacteria were harvested after 4 hrs by centrifugation
at 5,000× g for 30 min at 4°C. Inoculated autoinduction
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collected after 16 hrs at 5,000× g for 30 min at 4°C.
Purification of SUMO-SA2
For the isolation and purification of the SA2 peptide,
bacterial pellets were suspended in the lysis buffer (3 ml
for each gram of biomass) (20 mM Na2HPO4, 150 mM
NaCl, 20 mM imidazole, 5 mM MgCl2 1.5% N-lauroyl-
sarcosine, pH 8) supplemented with DNAse I 1 μg/ml
and chicken egg white lysozyme 300 μg/ml. The resulted
suspension was incubated on ice for 30 min. Subse-
quently, urea was added to the suspension to achieve
4 M final concentration. Lysis was accomplished using a
Braun Labsonic tip-sonicator (Braun Biotech, Melsungen,
Germany) for 5 min with 30 second stop between each
30 second pulse and passing two times through high
pressure homogenizer. Next, the cell lysate was centri-
fuged (30 minutes, 40.000 g, 20°C) and supernatant was
filtered through a 0.45 μm filter. SUMO-SA2 was puri-
fied by affinity chromatography using a 50 ml packed
column of Ni-NTA Superflow (Qiagen, Chatsworth, CA)
attached to an AKTA Purifier (GE Healthcare, Uppsala,
Sweden). The column was washed with 5 column volumes
of binding buffer (20 mM sodium phosphate, 0.5 M NaCl,
40 mM imidazole, pH 8) after which the cleared lysate
was loaded onto a 50 ml packed Ni2+-NTA column at
0.5 ml/min at room temperature. After loading the
cleared lysate, the column was washed with the binding
buffer until the A280 reached to the baseline. His-tagged
proteins were eluted from the column with elution buf-
fer (20 mM sodium phosphate, 0.5 M NaCl, 500 mM
imidazole, pH 8).
To remove excess imidazole and NaCl, the elution
buffer was exchanged with cleavage buffer (20 mM
hepes, 150 mM NaCl, pH 8.0) by loading onto a Hiprep
26/10 desalting column.
As the molecular weight of SA2 peptide (1.142 KD) is
8% of the molecular weight of the SUMO-SA2 (14295
KD), the highest expected amount of SA2 that can be
released after enzymatic cleavage can be calculated.
Purification of SUMO protease
The same protocol as described above was used for the
purification of SUMO protease without addition of urea.
Moreover, the elution buffer was replaced by the storage
buffer (50 mM NaH2PO4, 300 mM NaCl, 1 mM DTT,
pH 8.0) prior to protein quantification using the BCA
assay which BSA used as a standard. Finally, 0.2 mg/ml
dilutions were made by adding glycerol 50% (v/v) and
stored at −80°C until required.
Purification of SA2 peptide
SUMO protease was added at a 1:500 molar ratio to the
purified SUMO-SA2 solution supplemented with 1 mMDTT and the mixture was incubated under gentle shak-
ing for 6 hrs at 30°C to allow SUMO cleavage from the
SA2 peptide.
To separate SA2 peptide from cleaved SUMO, SUMO
protease and uncleaved SUMO-SA2, selective precipita-
tion by ethanol was performed.
The pH of protein solution after cleavage was adjusted
to 11.5 then ethanol was added up to 50% of the total
volume to precipitate all proteins except SA2. After cen-
trifugation at 5000xg at 4°C for 15 min, supernatant was
collected and pH of supernatant was adjusted to 2 by
adding 1 M HCl to precipitate SA2. The precipitate was
collected and suspended in 0.1 M HCl and centrifuged
at 5000× g at 4°C. This procedure was repeated 3 times.
Subsequently, recovered peptide was confirmed by
HPLC, and mass spectrometry. Finally the peptide pellet
was lyophilized at −50°C and at 0.5 mbar in a Chris
Alpha 1–2 freeze-drier (Osterode am Harz, Germany)
for 12 hrs and stored at −20°C.
Characterization of produced peptide
Gel electrophoresis
The produced proteins were evaluated by SDS-PAGE.
Samples were boiled in Laemmli sample buffer (Bio-Rad
Laboratories, Hercules, CA, USA) for 5 min and loaded
at 20 μl/well onto NuPAGE 10% Novex Bis-Tris gels (12
wells, 1.0-mm thickness; NuPAGE, Invitrogen, Carlsbad,
CA, USA). Electrophoresis was performed at room
temperature applying a constant voltage of 175 V for
50 min. The gel was stained with Page Blue™ Protein
Staining Solution (Fermentas GMBH, St. Leon-Rot,
Germany) and destained overnight by washing with RO
water.
Size exclusion chromatography
Cleavage of SUMO-SA2 was followed by Size Exclusion
Chromatography on a Superdex Peptide 10/300 GL col-
umn at a flow rate of 0.7 ml/min with phosphate buffered
saline at pH = 7.4 or pH = 11.5 as the mobile phase. Prior
to loading the samples a Gel Filtration LMW Calibration
kit (GE Healthcare, Uppsala, Sweden) was used to validate
column performance.
HPLC analysis and mass spectrometry
1 mg of Lyophilized SA2 peptide was dissolved in 1 ml
of DMSO and 20 μl of the peptide solution was diluted
5 times in RO water. 50 μl of prepared sample was
injected onto a Sunfire C18 column (waters Corporation,
Milford, USA). A gradient was run at 1.0 ml/min flow
rate from buffer A (5% actonitrile, 0.1% trifluoroacetic
acid, 95% water) in 30 minutes to buffer B (100% aceto-
nitrile, 0.1% trifluoroacetic acid). UV absorption was
monitored at 220 nm, 280 nm and also fluorescent
Rad-Malekshahi et al. Microbial Cell Factories  (2014) 13:178 Page 8 of 8emission at 350 nm of tryptophan residue upon excita-
tion at 295 nm was recorded.
Furthermore, Electrospray ionization (ESI) mass spec-
trometry was carried out using a Shimadzu LCMS QP-
8000(Duisburg, Germany) single quadrupole bench top
mass spectrometer (m/z range, 2000), coupled with a
QP-8000 data system.
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